Department of Medical Biotechnology and Nanotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Department of Research and Development, Production and Research Complex, Pasteur Institute of Iran, Tehran, Iran.
J Cell Biochem. 2019 Apr;120(4):5666-5676. doi: 10.1002/jcb.27850. Epub 2018 Oct 18.
Breast cancer is one of the most prevalent cancers in women. Triple-negative breast cancer consists 15% to 20% of breast cancer cases and has a poor prognosis. Cancerous transformation has several causes one of which is dysregulation of microRNAs (miRNAs) expression. Exosomes can transfer miRNAs to neighboring and distant cells. Thus, exosomal miRNAs can transfer cancerous phenotype to distant cells. We used gene expression omnibus (GEO) datasets and miRNA target prediction tools to find overexpressed miRNA in breast cancer cells and their target genes, respectively. Exosomes were extracted from MDA-MB-231 and MCF-7 cells and characterized. Overexpression of the miRNAs of MDA-MB-231 cells and their exosomes were analyzed using quantitative Real-time PCR. The target genes expression was also evaluated in the cell lines. Luciferase assay was performed to confirm the miRNAs: mRNAs interactions. Finally, MCF-7 cells were treated with MDA-MB-231 cells' exosomes. The target genes expression was evaluated in the recipient cells. GSE60714 results indicated that miR-9 and miR-155 were among the overexpressed miRNAs in highly metastatic triple negative breast cancer cells and their exosomes. Bioinformatic studies showed that these two miRNAs target PTEN and DUSP14 tumor suppressor genes. Quantitative Real-time PCR confirmed the overexpression of the miRNAs and downregulation of their targets. Luciferase assay confirmed that the miRNAs target PTEN and DUSP14. Treatment of MCF-7 cells with MDA-MB-231 cells' exosomes resulted in target genes downregulation in MCF-7 cells. We found that miR-9 and miR-155 were enriched in metastatic breast cancer exosomes. Therefore, exosomal miRNAs can transfer from cancer cells to other cells and can suppress their target genes in the recipient cells.
乳腺癌是女性中最常见的癌症之一。三阴性乳腺癌占乳腺癌病例的 15%至 20%,预后不良。癌症的发生有几个原因,其中之一是 microRNAs(miRNAs)表达的失调。外泌体可以将 miRNAs 转移到邻近和远处的细胞。因此,外泌体 miRNAs 可以将癌症表型转移到远处的细胞。我们使用基因表达综合数据库(GEO)数据集和 miRNA 靶标预测工具,分别找到乳腺癌细胞中过度表达的 miRNA 及其靶基因。从 MDA-MB-231 和 MCF-7 细胞中提取外泌体并进行表征。使用定量实时 PCR 分析 MDA-MB-231 细胞及其外泌体中 miRNA 的过表达。还评估了细胞系中靶基因的表达。进行荧光素酶测定以确认 miRNAs:mRNAs 相互作用。最后,用 MDA-MB-231 细胞的外泌体处理 MCF-7 细胞。在受体细胞中评估靶基因的表达。GSE60714 结果表明,miR-9 和 miR-155 是高度转移性三阴性乳腺癌细胞及其外泌体中过度表达的 miRNAs 之一。生物信息学研究表明,这两种 miRNA 靶向 PTEN 和 DUSP14 肿瘤抑制基因。定量实时 PCR 证实了 miRNA 的过表达和靶基因的下调。荧光素酶测定证实了 miRNA 靶向 PTEN 和 DUSP14。用 MDA-MB-231 细胞的外泌体处理 MCF-7 细胞导致 MCF-7 细胞中靶基因的下调。我们发现 miR-9 和 miR-155 在外泌体中富集在转移性乳腺癌中。因此,外泌体 miRNAs 可以从癌细胞转移到其他细胞,并可以在受体细胞中抑制其靶基因。